AlphaFold predicted structure
SHOC2 · Q9UQ13

Mean pLDDT
87.5/ 100
Confident
582 residues
Confidence breakdown
- Very high(≥ 90)83%
- Confident(70–90)2%
- Low(50–70)1%
- Very low(< 50)14%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
SHOC2 leucine rich repeat scaffold protein
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Adult solid tumours cancer susceptibility
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownChildhood solid tumours
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownChildhood solid tumours cancer susceptibility
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal hydrops
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIUGR and IGF abnormalities
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted+7 more panels — install the extension to see the full list inline on any page.
Noonan syndrome-like disorder with loose anagen hair
Noonan syndrome
RASopathy
neurodegenerative disease
Abnormality of the cardiovascular system
Noonan syndrome and Noonan-related syndrome
carcinoma of esophagus
Houge-Janssens syndrome 2
polycystic kidney disease 4
Pectus excavatum
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Leucine-rich repeat protein SHOC-2
Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates activation of the MAPK pathway (PubMed:10783161, PubMed:16630891, PubMed:25137548, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). Acts as a scaffolding protein in the SMP complex (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:10783161, PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The SMP complex enhances the dephosphorylation activity and substrate specificity of PP1c (PubMed:35768504, PubMed:36175670). Acts as an inhibitor of keratinocyte differentiation via interaction with RAS protein complexes that promote ERK activation (PubMed:23524970)
SHOC2 · Q9UQ13

Mean pLDDT
87.5/ 100
Confident
582 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0